Table 1 Demographic features of the study population
From: Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience
Control group, n = 44 | Thrombolysis group, n = 42 | p value* | ||
|---|---|---|---|---|
Sex | Male | 24 (54.5) | 29 (69) | 0.167 |
Female | 20 (45.5) | 13 (31) | ||
Age, mean ± SD (range) | 63.3 ± 14.7 (28–86) | 56.4 ± 13.8 (20–69) | 0.001 | |
Weight, mean ± SD (range) | 73.5 ± 11.6 (40–96) | 55 ± 16.5 (16–86) | 0.611 | |
Comorbidities | COPD | 4 (9.1) | 3 (7.1) | 0.741 |
CCF (RHF) | 5 (11.4) | 12 (28.6) | 0.045 | |
Previous PTE | 0 (0) | 1 (2.4) | 0.303 | |
Active cancer | 4 (9.1) | 3 (7.1) | 0.741 | |
Surgery and major trauma | 1 (2.3) | 6 (14.3) | 0.042 | |
Pregnancy | 0 (0) | 1 (2.4) | 0.303 | |
Immobilization | 2 (4.5) | 4 (9.5) | 0.365 | |
Estrogen use | 1 (2.3) | 2 (4.8) | 0.529 | |
DVT | 5 (11.4) | 4 (9.5) | 0.781 | |